1 – 6 of 6
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(
- Contribution to journal › Letter
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
- 2016
-
Mark
Limited impact of fibromodulin deficiency on the development of experimental skin fibrosis
2016) In Experimental Dermatology(
- Contribution to journal › Article
- 2014
-
Mark
Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma.
(
- Contribution to journal › Article
- 2013
-
Mark
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
(
- Contribution to journal › Article
- 2012
-
Mark
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis.
(
- Contribution to journal › Article